Literature DB >> 22301117

Increased QT interval dispersion predicts 15-year cardiovascular mortality in type 2 diabetic subjects: the population-based Casale Monferrato Study.

Sara Giunti1, Gabriella Gruden, Paolo Fornengo, Federica Barutta, Cristina Amione, Giuseppe Ghezzo, Paolo Cavallo-Perin, Graziella Bruno.   

Abstract

OBJECTIVE: To evaluate the predictive role of increased corrected QT (QTc) and QT interval dispersion (QTd) on all-cause and cardiovascular mortality in a large, unselected type 2 diabetic population. RESEARCH DESIGN AND METHODS: The prospective study included 1,357 type 2 diabetic patients from the Casale Monferrato Study. At baseline, QTc intervals >0.44 s and QTd intervals >0.08 s were considered abnormally prolonged. Both all-cause and cardiovascular mortality were assessed 15 years after the baseline examination.
RESULTS: During the follow-up period, 862 subjects per 12,450 person-years died. Multivariate analysis showed that the hazard ratio (HR) of cardiovascular mortality was significantly increased in subjects with prolonged QTd (1.26 [95% CI 1.02-1.55]) and was only slightly reduced after multiple adjustments. Conversely, prolonged QTc did not increase the HRs for all-cause or cardiovascular mortality.
CONCLUSIONS: Increased QTd predicts cardiovascular mortality after a long-term follow-up period in a large, unselected population of type 2 diabetic subjects.

Entities:  

Mesh:

Year:  2012        PMID: 22301117      PMCID: PMC3322722          DOI: 10.2337/dc11-1397

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


Diabetes is a known cardiovascular risk factor, and there is much interest in the identification of factors that may improve cardiovascular risk stratification in diabetic subjects, possibly by using noninvasive low-cost approaches. In the general population, prolonged corrected QT (QTc) and increased QT interval dispersion (QTd), reflecting abnormalities of ventricular myocardial repolarization, are independent predictors of mortality (1). However, in type 2 diabetic subjects, the predictive role of QTc and QTd on all-cause and cardiovascular mortality remains controversial because studies addressing this issue were performed on small cohorts and/or had relatively short follow-up periods and/or focused on populations representative of specific ethnic groups (2–9). Therefore, we performed a prospective study to assess the predictive role of increased QTc and QTd on all-cause and cardiovascular mortality in an unselected, large population of type 2 diabetic subjects after a long-term follow-up period.

RESEARCH DESIGN AND METHODS

The study base included 1,540 type 2 diabetic subjects residing in Casale Monferrato (93,477 inhabitants) in 1991 who were identified through diabetes clinics, general practitioners, hospital discharges, prescriptions, and sales records of reagent strips/syringes (10,11). Electrocardiogram (ECG) records suitable for QTc/QTd evaluation were available for 1,359 (88%) patients (580 male and 779 female). R-R and QT intervals were measured blindly by two observers on the resting ECG tracing, using five consecutive beats on a lead V5. The QT interval corrected for the previous cardiac cycle length (QTc) was calculated according to the Bazett equation (12). A QTc >0.44 s was considered abnormally prolonged. R-R and QT intervals also were measured for three consecutive cardiac cycles on the six thoracic leads. QTc dispersion was calculated using the difference between the maximum and the minimum QTc in any thoracic leads. A QTd >0.080 s was considered abnormally increased (10). The relevant time scale for the analysis was the time since diabetes diagnosis to death or to 31 December 2006 (11). During the follow-up period (1991–2006), patients were regularly evaluated (three to four times per year) at the diabetes clinic or by general practitioners. Information on both deaths and the causes of death was obtained from the demographic files of towns of residence, hospital discharges, and autopsy records. Causes of death were derived and coded according to the ICD-9 classification (11) by two independent observers. The role of QTc and QTd as independent predictors of cardiovascular and all-cause mortality was assessed using multivariate Cox proportional hazards models. The test for nonproportional hazard was performed using Shoenfeld residuals. The P value was two-sided and considered statistically significant when <0.05.

RESULTS

As previously reported (10), at the baseline examination subjects with increased QTc (n = 354) or QTd (n = 448) were older and had higher systolic and/or diastolic blood pressure. Patients with increased QTd also had greater creatinine and fibrinogen levels. Of 1,359 subjects recruited at baseline, information on vital status at follow-up was available for 1,357 patients (99.8%). During follow-up, 862 patients per 12,450 person-years died. Of these, 440 subjects died of cardiovascular disease. Relative to the reference category with QTd ≤0.08 s, the hazard ratio (HR) for cardiovascular mortality was 1.26 (95% CI 1.02–1.55) in patients with increased QTd and only was slightly reduced after multiple adjustment for age, sex, hypertension, smoking, apolipoprotein (apo)B-to-apoA1 ratio, HbA1c, coronary heart disease, and micro-/macroalbuminuria (Table 1). Conversely, prolonged QTc did not increase the HRs for all-cause or cardiovascular mortality. Tests for nonproportional hazard resulted as nonsignificant in all analyses.
Table 1

Mortality rates and results of Cox regression analyses in the Casale Monferrato Study by QTc and QTd

Mortality rates and results of Cox regression analyses in the Casale Monferrato Study by QTc and QTd

CONCLUSIONS

This study provides evidence that, in a large population-based cohort of type 2 diabetic patients, increased QTd confers increased long-term cardiovascular mortality risk, independently of other cardiovascular risk factors. Previous reports have suggested a similar conclusion. However, they were performed on small clinic-based type 2 diabetic cohorts (2,8,9) and had a relatively short follow-up period (3). A previous prospective study on an unselected type 2 diabetic population of American Indians showed the predictive value of ventricular repolarization abnormalities on cardiovascular mortality (4). Our results are in line with these findings and extend them to a European type 2 diabetic population. Unlike previous reports (2–6,9,12), the current study did not identify QTc as a predictor of all-cause (4–6,12) and/or cardiovascular (2,3,9,12) mortality, possibly because of differences in the study design (2–6,9,12) and prolonged QTc cutoff values (4). Compared with population-based studies, clinic-based studies (2,3,5,6,9,12) notoriously have a potential for a selection bias, such as selecting patients with more severe illness. Nevertheless, findings from the current study are consistent with the view that QTd is a better cardiovascular risk predictor than QTc in type 2 diabetic subjects (3). The prospective study design; the large population sample; the representativeness of the study base with regard to the Italian diabetic population; the high estimated completeness of ascertainment; the recruitment of subjects cared for by both general practitioners and diabetes clinics, thus limiting the effect of selection bias; and the centralized assessment of measurements are key strengths of our study. The main limitation is represented by the manual assessment of the QT interval. However, ECGs potentially interfering with accurate QT interval measurements were excluded, and analyses were performed blindly. Furthermore, the QTc for each subject was considered as the mean of the readings of two observers to minimize interobserver variability (10). The possibility that changes in QTc/QTd abnormalities occurred during follow-up cannot be excluded. However, QT abnormalities do not change significantly over time in type 2 diabetic patients (2). Furthermore, changes in repolarization later in time with respect to baseline would have resulted in an underestimation bias of HRs of QTc and QTd. Finally, coronary heart disease, micro-/macroalbuminuria, HbA1c, and the apoB-to-apoA1 ratio (10,13–15) have been found to be associated with increased QTc or QTd and/or cardiovascular morbidity/mortality. Therefore, adjustment for these factors could result in an overadjustment bias that would ultimately reduce the statistical significance of the HRs in the fully adjusted model 4. In conclusion, we found that increased QTd predicts cardiovascular mortality in type 2 diabetic subjects. This observation is of clinical relevance because it may help in identifying people at higher cardiovascular risk by using a noninvasive and low-cost tool.
  15 in total

1.  Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study.

Authors:  Dan Ziegler; Christian P Zentai; Siegfried Perz; Wolfgang Rathmann; Burkhard Haastert; Angela Döring; Christa Meisinger
Journal:  Diabetes Care       Date:  2007-12-17       Impact factor: 19.112

2.  QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study.

Authors:  A A Naas; N C Davidson; C Thompson; F Cummings; S A Ogston; R T Jung; R W Newton; A D Struthers
Journal:  BMJ       Date:  1998-03-07

3.  Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study.

Authors:  P M Okin; R B Devereux; B V Howard; R R Fabsitz; E T Lee; T K Welty
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

4.  The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus.

Authors:  P T Sawicki; S Kiwitt; R Bender; M Berger
Journal:  J Intern Med       Date:  1998-01       Impact factor: 8.989

5.  Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort.

Authors:  M Veglio; G Bruno; M Borra; G Macchia; G Bargero; N D'Errico; G F Pagano; P Cavallo-Perin
Journal:  J Intern Med       Date:  2002-04       Impact factor: 8.989

6.  QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes.

Authors:  P K Christensen; M A Gall; A Major-Pedersen; A Sato; P Rossing; L Breum; A Pietersen; J Kastrup; H H Parving
Journal:  Scand J Clin Lab Invest       Date:  2000-07       Impact factor: 1.713

7.  QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up.

Authors:  C Stettler; A Bearth; S Allemann; M Zwahlen; L Zanchin; M Deplazes; E R Christ; A Teuscher; P Diem
Journal:  Diabetologia       Date:  2006-11-10       Impact factor: 10.122

8.  Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study.

Authors:  Claudia R L Cardoso; Gil F Salles; Waldemar Deccache
Journal:  J Diabetes Complications       Date:  2003 Jul-Aug       Impact factor: 2.852

9.  Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study.

Authors:  Peter M Okin; Richard B Devereux; Elisa T Lee; James M Galloway; Barbara V Howard
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

10.  Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients.

Authors:  Gil F Salles; Katia V Bloch; Claudia R L Cardoso
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

View more
  11 in total

1.  Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.

Authors:  Hilary F Armstrong; Gina S Lovasi; Elsayed Z Soliman; Susan R Heckbert; Bruce M Psaty; John H M Austin; Jerry A Krishnan; Eric A Hoffman; Craig Johnson; Matthew J Budoff; Karol E Watson; R Graham Barr
Journal:  Respir Med       Date:  2016-12-08       Impact factor: 3.415

Review 2.  Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review.

Authors:  Markolf Hanefeld; Eva Duetting; Peter Bramlage
Journal:  Cardiovasc Diabetol       Date:  2013-09-21       Impact factor: 9.951

3.  Association of corrected QT interval with long-term mortality in patients with syncope.

Authors:  Nivas Balasubramaniyam; Chandrasekar Palaniswamy; Wilbert S Aronow; Sahil Khera; Gokulakrishnan Balasubramanian; Prakash Harikrishnan; Jay V Doshi; Christopher Nabors; Stephen J Peterson; Sachin Sule
Journal:  Arch Med Sci       Date:  2013-12-05       Impact factor: 3.318

4.  Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?

Authors:  Takayuki Miki; Toshiyuki Tobisawa; Tatsuya Sato; Masaya Tanno; Toshiyuki Yano; Hiroshi Akasaka; Atsushi Kuno; Makoto Ogasawara; Hiromichi Murase; Shigeyuki Saitoh; Tetsuji Miura
Journal:  Cardiovasc Diabetol       Date:  2014-08-21       Impact factor: 9.951

5.  Multiple logistic regression analysis of risk factors in elderly pneumonia patients: QTc interval prolongation as a prognostic factor.

Authors:  Yasuyuki Taooka; Gen Takezawa; Miki Ohe; Akihisa Sutani; Takeshi Isobe
Journal:  Multidiscip Respir Med       Date:  2014-11-22

6.  Comparison between QT Interval Parameters in Type 2 Diabetic and Nondiabetic Patients with Non-ST Elevation Myocardial Infarction.

Authors:  Hamid Reza Bonakdar; Masoumeh Aslanpour; Hassan Moladoust; Parham Sadeghipour; Fereshteh Mohamadi; Mohammad Assadian Rad; Jalal Kheirkhah
Journal:  J Tehran Heart Cent       Date:  2014-07-06

7.  The effect of 25-hydroxyvitamin D levels on QT interval duration and dispersion in type 2 diabetic patients.

Authors:  Demet Ozgil Yetkin; Belgin Kucukkaya; Mehtap Turhan; Merve Oren
Journal:  Croat Med J       Date:  2015-12       Impact factor: 1.351

8.  Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current: A Possible Therapeutic Approach.

Authors:  Hui Wang; Cao Wang; Yuan Lu; Yan Yan; Dongjing Leng; Shanshan Tian; Dongjie Zheng; Zhiguo Wang; Yunlong Bai
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

9.  Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study.

Authors:  Amanda J Cox; Amir Azeem; Joseph Yeboah; Elsayed Z Soliman; Shivani R Aggarwal; Alain G Bertoni; J Jeffrey Carr; Barry I Freedman; David M Herrington; Donald W Bowden
Journal:  Diabetes Care       Date:  2014-02-26       Impact factor: 19.112

10.  Ticagrelor-Induced Prolongation of the QTc Interval.

Authors:  Avik Ray; Ahmad Najmi; Gaurav Khandelwal; Balakrishnan Sadasivam
Journal:  Case Rep Cardiol       Date:  2019-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.